CRANFORD, N.J., Nov. 22, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) announced today that it will be executing a reverse stock split of its ...

The reverse stock split is primarily intended to enable the Company to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market. The new CUSIP ...

Globalstar (GSAT) announced its intent to transfer its common stock listing to Nasdaq in the first quarter of 2025. In connection with this planned uplisting, the company also announced that its ...

London, United Kingdom--(Newsfile Corp. - November 12, 2024) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-2 reverse stock split ...

DANBURY, Conn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) today announced that a 1-for-30 reverse stock split of its issued and outstanding shares of common stock will ...

RENO, Nev., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker of Battle Born Batteries® and an industry leader ...

The Company’s stockholders previously approved the reverse stock split and granted ... s shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market ...

The reverse stock split is intended, among other things ... requirement of $1.00 per share for continued listing on The Nasdaq Global Market. When the reverse stock split becomes effective ...

The Reverse Stock Split is primarily intended to bring the Company into compliance with the minimum average closing share price requirement for maintaining its listing on the Nasdaq Capital Market.

The Reverse Split affects all issued and outstanding shares of the Common Stock, as well as the number of shares of Common Stock available for issuance under the Company’s equity incentive plans.

The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November 18, 2024, and the Company’s common stock will open for trading on The Nasdaq Capital Market on a post-split ...

The reverse stock split aims to boost the company’s share price to comply with Nasdaq’s minimum bid requirements. This proactive measure seeks to secure Mainz Biomed’s continuous listing on ...